Meridian Bioscience, Inc. (VIVO) Tops Q1 EPS by 1c

January 23, 2013 7:39 AM EST Send to a Friend
Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q1 EPS of $0.20, $0.01 better than the analyst estimate of $0.19. Revenue for the quarter came in at $45.4 million versus the consensus estimate of $44.34 million.

Meridian Bioscience, Inc. reaffirmed FY2013 guidance.

For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment